Our aim was to elucidate if the modification of human serum albumin (HSA) under hyperglycemia-like conditions affects enzymatic activity of MPO, its release from neutrophils by degranulation and NETosis, and the generation of ROS and RHS by neutrophils, which are key factors of neutrophil bactericidal activity. The gene discussed is MPO; the disease is Hyperglycemia.